A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients

Summary

The goal of this clinical trial is to learn about the following questions in the patients receiving maintenance hemodialysis with elevated blood phosphorus: * How much effect AP-306 has assessed by blood phosphorus lowering; * How safe and tolerable AP-306 is. Participants will receive either following treatments: * AP-306, and * Sevelamer carbonate.

Timeline

Start

2023-02-20

Primary completion

2023-08-25

Completion

2023-09-14

Drugs

Indications